Skip to main content
New Horizon Biotech Ltd.
New Horizon Biotech Ltd.
Your life is our life
  • New Horizon Biotech Team

    New Horizon Biotech is powered by a diverse global workforce of approximately 800 professionals dedicated to advancing diabetes management technologies. Our team spans engineering, manufacturing, regulatory coordination, quality assurance, supply chain planning, and market support, working across a connected international footprint that includes Shenzhen, Seattle, Budapest, and Monterrey. Together, we combine technical expertise, operational discipline, and a shared commitment to delivering dependable medical device solutions for modern healthcare markets. 

Use this line to say something about what you do. Add useful information that your visitors may find interesting.

Based in Shenzhen, Dr. Li Wen leads NHB as President and CEO, guiding the company’s global strategy and overall operations across its international network. With a background in medical device leadership and cross-functional execution, he supports enterprise governance, product and manufacturing excellence, and growth initiatives spanning market expansion, operational coordination, and long-term business development.

Dr. Li Wen

Based in the United States, Kenneth Xu leads NHB’s North America operations while driving strategic transformation initiatives across the company’s global network. With a background in program leadership and cross-functional execution, he supports operational coordination, enterprise governance, and innovation efforts spanning digital transformation, AI-enabled initiatives, and long-term business growth. 

Mr. Kenneth Xu

Based in Europe, Daniel Fischer leads NHB’s operational and business development activities across key European markets. He works closely with regional partners and internal teams to support market access, strengthen commercial relationships, and coordinate local execution across compliance, manufacturing, and customer-facing functions. His role is focused on turning NHB’s broader strategy into growth.

Mr. Daniel Fischer

Interested in learning more about New Horizon Biotech?